TTK Healthcare Limited has announced the opening of a special window for the transfer and dematerialization of physical securities, following a SEBI circular dated January 30, 2026. The healthcare company has taken proactive steps to inform shareholders about this regulatory opportunity through multiple communication channels.

SEBI Special Window Details

The special window has been established pursuant to SEBI Circular on Ease of Doing Investment – Special Window for Transfer and Dematerialisation of Physical Securities. This initiative provides shareholders with a structured mechanism to convert their physical securities holdings into electronic format.

Compliance and Communication

TTK Healthcare has fulfilled its regulatory disclosure obligations under Regulation 30 by informing both BSE Limited and National Stock Exchange of India Limited about the special window opening. The company published the notice in Business Standard (English Version) across four editions on Tuesday, February 17, 2026.

Multi-Channel Approach

The company has adopted a comprehensive communication strategy to reach shareholders:

• Print Media: Published in Business Standard newspaper
• Digital Platform: Posted on company's LinkedIn page
• Corporate Website: Made available under Investor Relations section at www.ttkhealthcare.com
• Stock Exchanges: Formal disclosure to BSE and NSE

Shareholder Benefits and Restrictions

The special window covers transfer requests that were previously submitted but rejected or remained unattended due to document deficiencies or process issues. However, certain cases are excluded from this window, including disputes between transferor and transferee, and securities already transferred to the Investor Education and Protection Fund (IEPF).

Contact Information for Assistance

Shareholders seeking assistance with the transfer process can contact the company's Registrar and Transfer Agent, M/s Data Software Research Co. Pvt. Ltd. For queries, shareholders may write to investorcare@ttkhealthcare.com or dsrc@dsrc-cid.in . The notice was signed by Gowry A Jaishankar, DGM - Legal & Company Secretary, and digitally authenticated on February 18, 2026.

TTK Healthcare Limited has announced the completion of tenure of its Independent Director Mr. N Ramesh Rajan, marking the end of his second and final term with the company. The announcement was made through a regulatory filing under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations, 2015.

Director Tenure Details

Mr. N Ramesh Rajan, holding Director Identification Number (DIN) 01628318, completed his second and final term as Independent Director on February 02, 2026. Following the completion of his tenure, he ceases to be a Director of the company and Member/Chairman of the Committees of the Board of Directors, with effect from February 03, 2026.

Regulatory Compliance

The company has confirmed that notwithstanding Mr. Rajan's retirement, the composition of the Board and its Committees continue to be in compliance with the requirements of applicable laws. This ensures that TTK Healthcare maintains its governance standards and regulatory adherence despite the directorial change.

Board Appreciation

The Board of Directors and Management of TTK Healthcare expressed deep appreciation and gratitude to Mr. N Ramesh Rajan for his extensive contribution to the company during his tenure as Independent Director. The Board extended their best wishes to him following the completion of his service.

Regulatory Filing

The disclosure was made pursuant to Regulation 30 of the Listing Regulations, read with SEBI Circular dated July 13, 2023. The company has indicated that this information is also available on its official website at www.ttkhealthcare.com . The regulatory communication was signed by Gowry A Jaishankar, DGM - Legal & Company Secretary, on February 02, 2026.